Related Experiment Video
Updated: May 28, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Case study and review: treatment of tricuspid prosthetic valve thrombosis
David Yi Zhang1, Jay Lozier, Richard Chang
1Division of Internal Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Abstract:
Prosthetic valve thrombosis (PVT) is a severe and life-threatening complication of heart valve replacement. Conventional therapy is surgical thrombectomy or valve replacement. Medical thrombolysis is another emerging option. We report the case of a 57 year old woman with a history of Ebstein anomaly who underwent successful treatment of tricuspid prosthetic valve thrombosis with intra-atrial infusion of very low dose recombinant tissue plasminogen activator (tPA). We review the presentation, etiology, diagnosis, and treatment of tricuspid PVT emphasizing a modified medical option as a safe, minimally invasive alternative to surgical intervention or conventional medical therapy for tricuspid valve thrombosis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Endocarditis III: Medical Management
Mitral Regurgitation III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
